GLP-3, commonly referred to in research contexts as glucagon-like peptide–3–related signaling, represents an area of ongoing scientific investigation within the broader family of glucagon-derived peptides. While GLP-1 and GLP-2 are well-characterized hormones involved in metabolic and gastrointestinal regulation, GLP-3 is not currently recognized as an established endogenous hormone in human physiology but is sometimes referenced in exploratory or theoretical peptide research.

Within glucagon peptide research, investigators study receptor-mediated pathways that influence appetite regulation, glucose metabolism, gastrointestinal function, and energy balance. Experimental analogs within this peptide family are typically evaluated for their potential to interact with glucagon, GLP-1, or related receptors to influence metabolic signaling cascades under controlled conditions.

Ongoing research in glucagon-derived peptide biology continues to expand understanding of receptor interactions, endocrine cross-talk, and metabolic homeostasis. Clarification of terminology is important, as not all peptide designations correspond to naturally occurring or clinically established hormones.